Welcome to our dedicated page for Federated Hermes SEC filings (Ticker: FHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Federated Hermes, Inc. (NYSE: FHI) SEC filings page provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Federated Hermes is a Pennsylvania-incorporated global active investment manager, and its filings document material events, financial results and significant agreements affecting the business.
Among the most relevant documents for FHI are its current reports on Form 8-K. Recent 8-K filings include earnings releases reporting quarterly financial and operating results, with details on revenue, operating expenses, nonoperating income, net income and earnings per share. These filings also describe how revenue is derived from money market, equity, fixed-income and alternative/private markets and multi-asset assets, and provide context on assets under management across these categories.
Other 8-Ks cover material definitive agreements and strategic transactions, such as the Sale and Purchase Agreement under which Federated Hermes agreed to acquire an 80% interest in FCP Fund Manager, L.P., a U.S. real estate investment manager. The related filing outlines the structure of the transaction, purchase price components, conditions to closing and governance arrangements, offering insight into how Federated Hermes is expanding its private markets and real estate capabilities.
Federated Hermes also uses 8-K filings to disclose leadership and governance changes, including executive succession at the Federated Advisory Companies and Federated Securities Corp., and changes in board roles. These filings provide formal notice of transitions in key management positions and board composition.
On Stock Titan, FHI filings are updated as they become available from EDGAR. AI-powered tools can help summarize lengthy documents such as earnings releases and transaction-related exhibits, highlighting key figures, asset mix information and major contractual terms. Users can review Forms 10-K and 10-Q for comprehensive annual and quarterly reporting, and Forms 8-K for event-driven updates, while AI-generated insights assist in understanding how developments in assets under management, revenue composition, expenses and strategic deals may shape Federated Hermes’ business profile over time.
FEDERATED HERMES, INC. Chairman, President & CEO J. Christopher Donahue reported an acquisition of 34,904 shares of Class B common stock as a grant or award on March 5, 2026. Following this award, his directly held Class B common stock increased to 479,192 shares.
Federated Hermes, Inc. vice president Paul A. Uhlman reported two Class B common stock transactions. He sold 11,739 shares in an open‑market transaction at a weighted average price of $56.5291 per share to satisfy tax obligations from vesting restricted stock. He also received a grant or award of 20,684 shares at no cost, bringing his directly held balance to 336,379 shares.
FEDERATED HERMES, INC. Principal Accounting Officer Richard A. Novak reported two transactions in Class B Common Stock. On the same date, he executed an open-market sale of 867 shares at a weighted average price of $56.4932 per share, described as a sale to satisfy tax obligations from the vesting of restricted stock. He also received a grant or award of 2,576 shares at no cost. After these transactions, he directly owned 45,209 Class B shares.
FEDERATED HERMES, INC. reported that Vice President Theodore W. Zierden III acquired 8,894 shares of Class B Common Stock on a grant or award basis. The shares were recorded at a price of $0.00 per share, indicating a non-cash equity award. Following this transaction, his directly held stake increased to 160,750 shares of Class B Common Stock.
Charles Schwab Corp submitted a Form 144 to sell 30,000 Class B shares.
The filing lists restricted stock awards by grant date and amount: 03/06/2023: 13,974; 03/06/2024: 11,579; 03/03/2022: 2,597; 11/18/2019: 925; 11/17/2023: 925. The filing shows 75,965,666 shares outstanding as of 03/06/2026.
FHI: Morgan Stanley Smith Barney LLC submitted a Form 144 notice to sell 448 shares of Class B Common tied to restricted stock vesting under a registered plan on 03/03/2026. The filing date shown is 03/05/2026 and the shares are listed for sale on the NYSE.
FHI files a Form 144 to sell 11,739 shares of Class B Common that vested under a registered plan.
Broker is Morgan Stanley Smith Barney LLC. The filing lists an aggregate offering price of $663,595.10, total outstanding shown as 75,974,666, dates 03/03/2026 (vesting) and 03/05/2026, and exchange NYSE.
Saker Anwar Nusseibeh submitted a Form 144 disclosing a proposed sale of 6,161 Class B Common shares of FHI through Morgan Stanley Smith Barney LLC, dated 03/05/2026. The notice cites restricted stock vesting under a registered plan on 03/03/2026. The filing also records a prior sale of 5,800 common shares on 02/02/2026 for $311,239.60.
Richard Novak reported an intended sale of 867 Class B Common shares tied to restricted stock vesting under a registered plan on 03/03/2026.
The filing also lists a prior sale of 14,000 common shares on 02/17/2026 for $773,544.80.